Effectiveness, safety and potential predictors of response at week 16 in patients with severe hidradenitis suppurativa treated with secukinumab: A multicenter observational retrospective study

被引:0
|
作者
Serrano, Pablo Fernandez-Crehuet [3 ,4 ]
Haselgruber-deFrancisco, Sofia [1 ]
Padial-Gomez, Alicia [5 ]
Vasquez-Chinchay, Fiorella [6 ]
Fernandez-Ballesteros, Maria D. [7 ]
Lopez-Riquelme, Irene [7 ]
Jimenez-Gallo, David [8 ]
Segura-Palacios, Juan M. [9 ]
Contreras-Steyls, Marisol [10 ]
Osorio-Gomez, Guiovana F. [11 ]
Hernandez-Rodriguez, Juan Carlos [11 ]
Cuenca-Barrales, Carlos [1 ]
Molina-Leyva, Alejandro [1 ,2 ]
机构
[1] Hosp Univ Virgen de las Nieves, IBS Granada, Hidradenitis Suppurativa Clin, Granada, Spain
[2] European Hidradenitis Suppurativa Fdn, Dessau Rosslau, Germany
[3] Hosp Reina Sofia Cordoba, Cordoba, Spain
[4] IMIBIC, Dept Dermatol, Cordoba, Spain
[5] Hosp Univ Jerez de la Frontera, Dept Dermatol, Jerez de la Frontera, Spain
[6] Hosp Univ Virgen Valme, Dept Dermatol, Seville, Spain
[7] Hosp Univ Reg Malaga, Dept Dermatol, Malaga, Spain
[8] Hosp Univ Puerta Mar, Dept Dermatol, Cadiz, Spain
[9] Hosp Costa Sol, Dept Dermatol, Marbella, Spain
[10] Hosp Univ Virgen de la Victoria, Dept Dermatol, Malaga, Spain
[11] Hosp Univ Virgen de Rocio, Dept Dermatol, Seville, Spain
关键词
D O I
暂无
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
引用
收藏
页码:108 / 108
页数:1
相关论文
共 50 条
  • [41] Secukinumab Demonstrated High Effectiveness in Vietnamese Patients with Moderate-To-Severe Plaque Psoriasis in a Real-World Clinical Setting: 16 Week Results from an Observational Study
    Nguyen, Hao T.
    Pham, Nhi T. U.
    Tran, Tu N. A.
    Nguyen, Nhuong T. T.
    Vu, Thao T. P.
    DERMATOLOGY AND THERAPY, 2021, 11 (05) : 1613 - 1621
  • [42] COVID-19 and treatment with biologics: Safety insights from the phase 3 studies of secukinumab in patients with moderate-to-severe hidradenitis suppurativa
    Muscianisi, Elisa
    Potocki, Anne-Christine
    Keefe, Deborah
    Thomas, Nicolas
    Kasparek, Torben
    Kimball, Alexa B.
    Gottlieb, Alice B.
    Alavi, Afsaneh
    Reguiai, Ziad
    Jemec, Gregor B. E.
    EXPERIMENTAL DERMATOLOGY, 2021, 30 : 77 - 78
  • [43] Effectiveness and safety of nivolumab in patients with advanced melanoma: A multicenter, observational study
    Monestier, Sandrine
    Dalle, Stephane
    Mortier, Laurent
    Dutriaux, Caroline
    Dalac-Rat, Sophie
    Meyer, Nicolas
    Leccia, Marie Therese
    Mansard, Sandrine
    Montaudie, Henri
    Saiag, Philippe
    Combemale, Patrick
    Guillot, Bernard
    Skowron, Francois
    Duval Modeste, Anne-Benedicte
    Beneton, Nathalie
    Hainaut, Ewa
    Robert, Caroline
    Arnault, Jean Philippe
    Le Corre, Yannick
    Jouary, Thomas
    Ameur, Nabahet
    Varey, Emilie
    Khammari, Amir
    Dreno, Brigitte
    INTERNATIONAL JOURNAL OF CANCER, 2021, 148 (11) : 2789 - 2798
  • [44] Effectiveness, safety, and predictors of response to ultrasound-guided stellate ganglion blockades for the treatment of patients with chronic migraine: A retrospective and observational study
    Yu, Bin
    Zhang, Wei
    Zhao, Chunmei
    Xing, Yan
    Meng, Lan
    Luo, Fang
    PAIN PRACTICE, 2023, 23 (06) : 609 - 617
  • [45] Real-World Effectiveness and Safety of Tildrakizumab for Moderate-to-Severe Plaque Psoriasis in Adult Patients: A 52-Week Multicenter Retrospective Study
    Yeung, Jensen
    Sood, Siddhartha
    JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2024,
  • [46] Hidradenitis Suppurativa in the Pediatric Population An International, Multicenter, Retrospective, Cross-sectional Study of 481 Pediatric Patients
    Liy-Wong, Carmen
    Kim, Mary
    Kirkorian, A. Yasmine
    Eichenfield, Lawrence F.
    Diaz, Lucia Z.
    Horev, Amir
    Tollefson, Megha
    Oranges, Teresa
    Philips, Roderic
    Chiu, Yvonne E.
    Ghafari, Ghazal
    Arnold, Justin D.
    Sprague, Jessica
    Nguyen, Henry
    Wan, Stephanie
    Atenafu, Eshetu G.
    Pope, Elena
    Hamilton, Jill
    Naik, Haley B.
    Lara-Corrales, Irene
    JAMA DERMATOLOGY, 2021, 157 (04) : 385 - 391
  • [47] Effectiveness and safety of ustekinumab 90 mg in patients weighing 100 kg or less: a retrospective, observational, multicenter study
    del Alcazar, Elena
    Ferran, Marta
    Lopez-Ferrer, Anna
    Notario, Jaime
    Vidal, David
    Riera, Jose
    Aparicio, Gloria
    Gallardo, Fernando
    Vilarrasa, Eva
    Alsina, Merce
    Puig, Lluis
    Ferrandiz, Carlos
    Carrascosa, Jose M.
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2020, 31 (03) : 222 - 226
  • [48] Real-World Safety and Effectiveness of Benralizumab in Japanese Patients with Severe Asthma: A Multicenter Prospective Observational Study
    Yamaguchi, Masao
    Nishimura, Yoshihiro
    Takumi, Yuko
    Hayashi, Nobuya
    Sakamoto, Kei
    Tohda, Yuji
    JOURNAL OF ASTHMA AND ALLERGY, 2024, 17 : 45 - 60
  • [49] A retrospective, observational multicenter study of 141 patients treated with ustekinumab 90 mg
    Llamas-Velasco, Mar
    Baniandres, Ofelia
    Rivera, Raquel
    Reymundo Jimenez, Ana
    Hospital, Mercedes
    Garcia Zamora, Elena
    Gonzalez-Cantero, Alvaro
    Andres Lencina, Juan-Jose
    Dauden, Esteban
    de la Cueva, Pablo
    DERMATOLOGIC THERAPY, 2020, 33 (04)
  • [50] Secukinumab in moderate-to-severe hidradenitis suppurativa (SUNSHINE and SUNRISE): week 16 and week 52 results of two identical, multicentre, randomised, placebo-controlled, double-blind phase 3 trials
    Kimball, Alexa B.
    Jemec, Gregor B. E.
    Alavi, Afsaneh
    Reguiai, Ziad
    Gottlieb, Alice B.
    Bechara, Falk G.
    Paul, Carle
    Bourboulis, Evangelos J. Giamarellos
    Villani, Axel P.
    Schwinn, Andreas
    Rueff, Franziska
    Ramaya, Larisha Pillay
    Reich, Adam
    Lobo, Ines
    Sinclair, Rodney
    Passeron, Thierry
    Martorell, Antonio
    Mendes-Bastos, Pedro
    Kokolakis, Georgios
    Becherel, Pierre-Andre
    Wozniak, Magdalena B.
    Martinez, Angela Llobet
    Wei, Xiaoling
    Uhlmann, Lorenz
    Passera, Anna
    Keefe, Deborah
    Martin, Ruvie
    Field, Clarice
    Chen, Li
    Vandemeulebroecke, Marc
    Ravichandran, Shoba
    Muscianisi, Elisa
    LANCET, 2023, 401 (10378): : 747 - 761